Study Finds Potential Treatment for Knee Cartilage Regeneration

Joint issues affect individuals of all ages, with many young people experiencing knee pain and seeking surgical options for relief. Researchers at Stanford Medicine have identified a treatment that may help regenerate damaged knee cartilage and prevent osteoarthritis following knee injuries. The study, conducted on older mice, focuses on the protein 15-PGDH, which is linked to the loss of tissue function as individuals age. Blocking this protein has been associated with increased muscle mass, endurance, and regeneration of various cell types. The treatment resulted in the production of new, functional joint cartilage, which was unexpected according to senior study author Nidhi Bhutani. The research also indicated that the treatment could reduce the likelihood of developing arthritis after a traumatic knee injury. Mice treated with the 15-PGDH inhibitor showed a thicker cartilage surface and a lower incidence of arthritis compared to untreated mice. The findings suggest that existing cartilage cells can change their gene expression patterns to facilitate healing, offering potential clinical implications for treating arthritis. While the study's results are based on mouse models, an oral version of the 15-PGDH inhibitor has been shown to be safe in humans, indicating the need for future clinical trials to assess its effectiveness for cartilage regeneration.